Long-term efficacy, safety and PK data of TH1902 (sudocetaxel zendusortide) in solid tumors: A novel SORT1-targeting peptide-drug-conjugate (PDC).

Wednesday, June 19, 2024

Dr. Minal Barve

Click above link to view abstract.

ASCO 2024 Poster for Trial 21-46

ASCO 2024 Poster for Trial 21-46